Hyaluronate and Derivatives and Lorcaserin Extended-Release Tablets
Determining the interaction of Hyaluronate and Derivatives and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Lorcaserin Hydrochloride
- Hyaluronate and Derivatives-Lorcaserin Tablets
- Hyaluronate and Derivatives-Lorcet
- Hyaluronate and Derivatives-Lorcet Plus
- Hyaluronate and Derivatives-Lorcet Tablets
- Hyaluronate and Derivatives-Lorlatinib
- Lorcaserin Extended-Release Tablets-Hyaluronate and Derivatives Injection (Knee)
- Lorcaserin Extended-Release Tablets-Hyaluronate sodium Injection
- Lorcaserin Extended-Release Tablets-Hyaluronidase
- Lorcaserin Extended-Release Tablets-Hyaluronidase and immune globulin
- Lorcaserin Extended-Release Tablets-Hyaluronidase and rituximab
- Lorcaserin Extended-Release Tablets-Hyaluronidase and trastuzumab